Anti-TNF-α Agents in the Treatment of Immune-Mediated Inflammatory Diseases: Mechanisms of Action and Pitfalls
The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
TNF-α is a potent inducer of the inflammatory response, a key regulator of innate immunity and plays an important role in the regulation of Th1 immune responses against intracellular bacteria and certain viral infections. However, dysregulated TNF can also contribute to numerous pathological situations. These include immune-mediated inflammatory diseases (IMIDs) including rheumatoid arthritis, Crohn's disease, psoriatic arthritis, ankylosing spondylitis, ulcerative colitis and severe chronic plaque psoriasis. Animal and human studies concerning the role of TNF-α in IMIDs have led to the development of a therapy based on TNF blockage. This article focuses first on the potential mechanisms by which the three currently licensed agents, adalimumab, etarnecept and infliximab, decrease the inflammatory activity of patients with different IMIDs. Second, it focuses on the risks, precautions and complications of the use of TNF-α inhibitors in these patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An endotoxin-induced serum factor that causes necrosis of tumors
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
Lipsky, P. E., van der Heijde, D. M. F. M., St. Clair, E. W., Furst, D. E., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Weisman, M., Emery, P., Feldmann, M., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011303432202 · Cited by 2,996
Bongartz, T., Sutton, A. J., Sweeting, M. J., Buchan, I., Matteson, E. L., & Montori, V. (2006) · JAMA · doi:10.1001/jama.295.19.2275 · Cited by 2,468
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
Tracey, D., Klareskog, L., Sasso, E. H., Salfeld, J. G., & Tak, P. P. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.10.001 · Cited by 1,628
Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy
Ehrenstein, M. R., Evans, J. G., Singh, A., Moore, S., Warnes, G., Isenberg, D. A., & Mauri, C. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040165 · Cited by 1,252
The Tumor Necrosis Factor Ligand and Receptor Families
Bazzoni, F., & Beutler, B. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342607 · Cited by 1,225
TNF downmodulates the function of human CD4+CD25hi T-regulatory cells
Valencia, X., Stephens, G., Goldbach-Mansky, R., Wilson, M., Shevach, E. M., & Lipsky, P. E. (2006) · Blood · doi:10.1182/blood-2005-11-4567 · Cited by 781
Natural regulatory T cells: mechanisms of suppression
Miyara, M., & Sakaguchi, S. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.01.003 · Cited by 711
Construction and initial characterization of a mouse-human chimeric anti-TNF antibody
Knight, D. M., Trinh, H., Le, J., Siegel, S., Shealy, D., McDonough, M., Scallon, B., Moore, M. A., Vilcek, J., Daddona, P., et al. (1993) · Molecular Immunology · doi:10.1016/0161-5890(93)90106-l · Cited by 703
Scallon, B. (1995) · Cytokine · doi:10.1006/cyto.1995.0029 · Cited by 675
Binding and Functional Comparisons of Two Types of Tumor Necrosis Factor Antagonists
Scallon, B., Cai, A., Solowski, N., Rosenberg, A., Song, X.-Y., Shealy, D., & Wagner, C. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.2.418 · Cited by 672
Matrix metalloproteinases in tumour invasion and metastasis
Curran, S., & Murray, G. I. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199911)189:3<300::aid-path456>3.0.co;2-c · Cited by 661
Ekström Smedby, K., Vajdic, C. M., Falster, M., Engels, E. A., Martínez-Maza, O., Turner, J., Hjalgrim, H., Vineis, P., Seniori Costantini, A., Bracci, P. M., et al. (2008) · Blood · doi:10.1182/blood-2007-10-119974 · Cited by 624
Lügering, A., Schmidt, M., Lügering, N., Pauels, H.-G., Domschke, W., & Kucharzik, T. (2001) · Gastroenterology · doi:10.1053/gast.2001.28702 · Cited by 588
Peyrin–Biroulet, L., Deltenre, P., de Suray, N., Branche, J., Sandborn, W. J., & Colombel, J. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.03.014 · Cited by 577
Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease
ten Hove, T. (2002) · Gut · doi:10.1136/gut.50.2.206 · Cited by 545
Risk of Herpes Zoster in Patients With Rheumatoid Arthritis Treated With Anti–TNF-α Agents
Strangfeld, A. (2009) · JAMA · doi:10.1001/jama.2009.146 · Cited by 542
Charles, P. J., Elliott, M. J., Davis, D., Potter, A. R., Kalden, J. R., Antoni, C., Breedveld, F. C., Js, S., Eberl, G., DeWoody, K. L., et al. (1999) · PubMed · Cited by 531
Nadkarni, S., Mauri, C., & Ehrenstein, M. R. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061531 · Cited by 507
Mackey, A. C., Green, L., Liang, L., Dinndorf, P., & Avigan, M. (2007) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e31802f6424 · Cited by 506
Tumour necrosis factor and Crohn's disease.
Van Deventer, S. J. (1997) · Gut · doi:10.1136/gut.40.4.443 · Cited by 500
Nesbitt, A., Fossati, G., Bergin, M., Stephens, P., Stephens, S., Foulkes, R., Brown, D., Robinson, M., & Bourne, T. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20225 · Cited by 477
Charles, P., Elliott, M. J., Davis, D., Potter, A., Kalden, J. R., Antoni, C., Breedveld, F. C., Smolen, J. S., Eberl, G., deWoody, K., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.3.1521 · Cited by 436
Biological functions of tumor necrosis factor cytokines and their receptors
Pfeffer, K. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(03)00022-4 · Cited by 415
Taylor, P. C., Peters, A. M., Paleolog, E., Chapman, P. T., Elliott, M. J., McCloskey, R., Feldmann, M., & Maini, R. N. (2000) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200001)43:1<38::aid-anr6>3.0.co;2-l · Cited by 405
Tak, P. P., Taylor, P. C., Breedveld, F. C., Smeets, T. J. M., Daha, M. R., Kluin, P. M., Meinders, A. E., & Maini, R. N. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390702 · Cited by 377
Anti-Cytokine Therapy for Rheumatoid Arthritis
Maini, R. N., & Taylor, P. C. (2000) · Annual Review of Medicine · doi:10.1146/annurev.med.51.1.207 · Cited by 376
TNF Inhibition Rapidly Down-Regulates Multiple Proinflammatory Pathways in Psoriasis Plaques
Gottlieb, A. B., Chamian, F., Masud, S., Cardinale, I., Abello, M. V., Lowes, M. A., Chen, F., Magliocco, M., & Krueger, J. G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.4.2721 · Cited by 372
Ohno, S., Nakamura, S., Hori, S., Shimakawa, M., Kawashima, H., Mochizuki, M., Sugita, S., Ueno, S., Yoshizaki, K., & 稲葉, 午. (2004) · PubMed · Cited by 343
Ledingham, J., Deighton, C., & on behalf of the British Society for Rheumatology Standards, G. A. A. W. G. (2005) · Rheumatology · doi:10.1093/rheumatology/keh464 · Cited by 331
Bruns, H., Meinken, C., Schauenberg, P., Härter, G., Kern, P., Modlin, R. L., Antoni, C., & Stenger, S. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38482 · Cited by 307
TNFα blockade in human diseases: Mechanisms and future directions
Wong, M., Ziring, D., Korin, Y., Desai, S., Kim, S., Lin, J., Gjertson, D., Braun, J., Reed, E., & Singh, R. R. (2008) · Clinical Immunology · doi:10.1016/j.clim.2007.08.013 · Cited by 307
Eissner, G., Kolch, W., & Scheurich, P. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2004.03.011 · Cited by 298
Etiology and Pathogenesis of Rheumatoid Arthritis
Firestein, G. S. (2017) · Kelley and Firestein's Textbook of Rheumatology · doi:10.1016/b978-0-323-31696-5.00069-3 · Cited by 278
Mitoma, H., Horiuchi, T., Hatta, N., Tsukamoto, H., Harashima, S.-I., Kikuchi, Y., Otsuka, J., Okamura, S., Fujita, S., & Harada, M. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.060 · Cited by 270
Catrina, A. I., Trollmo, C., af Klint, E., Engstrom, M., Lampa, J., Hermansson, Y., Klareskog, L., & Ulfgren, A. K. (2005) · Arthritis & Rheumatism · doi:10.1002/art.20764 · Cited by 255
Paleolog, E. M., Hunt, M., Elliott, M. J., Feldmann, M., Maini, R. N., & Woody, J. N. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390703 · Cited by 240
Tumor necrosis factor‐α antagonists and neuropathy
Stübgen, J. (2008) · Muscle & Nerve · doi:10.1002/mus.20924 · Cited by 236
Smeets, T. J. M., Kraan, M. C., van Loon, M. E., & Tak, P. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11098 · Cited by 224
Biology of tumor necrosis factor‐α– implications for psoriasis
Schottelius, A. J. G., Moldawer, L. L., Dinarello, C. A., Asadullah, K., Sterry, W., & Edwards, C. K. (2004) · Experimental Dermatology · doi:10.1111/j.0906-6705.2004.00205.x · Cited by 195
Di Sabatino, A. (2004) · Gut · doi:10.1136/gut.53.1.70 · Cited by 186
Catrina, A. I. (2002) · Rheumatology · doi:10.1093/rheumatology/41.5.484 · Cited by 181
Brennan, F. M., Browne, K. A., Green, P. A., Jaspar, J. M., Maini, R. N., & Feldmann, M. (1997) · Rheumatology · doi:10.1093/rheumatology/36.6.643 · Cited by 179
Kollias, G., & Kontoyiannis, D. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(02)00019-9 · Cited by 177
Rudwaleit, M., Siegert, S., Yin, Z., Eick, J., Thiel, A., Radbruch, A., Sieper, J., & Braun, J. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/ard.60.1.36 · Cited by 171
Interstitial Granulomatous Dermatitis Associated With the Use of Tumor Necrosis Factor α Inhibitors
Deng, A., Harvey, V., Sina, B., Strobel, D., Badros, A., Junkins-Hopkins, J. M., Samuels, A., Oghilikhan, M., & Gaspari, A. (2006) · Archives of Dermatology · doi:10.1001/archderm.142.2.198 · Cited by 168
Serious infections during anti-TNFα treatment in rheumatoid arthritis patients
Favalli, E. G., Desiati, F., Atzeni, F., Sarzi‐Puttini, P., Caporali, R. F., Bobbio‐Pallavicini, F., Gorla, R., Filippini, M., & Marchesoni, A. (2008) · Autoimmunity Reviews · doi:10.1016/j.autrev.2008.11.002 · Cited by 168
Komano, Y., Harigai, M., Koike, R., Sugiyama, H., Ogawa, J., Saito, K., Sekiguchi, N., Inoo, M., Onishi, I., Ohashi, H., et al. (2009) · Arthritis Care & Research · doi:10.1002/art.24283 · Cited by 156
Guideline for anti-TNF-α therapy in psoriatic arthritis
Kyle, S., Chandler, D., Griffiths, C. E. M., Helliwell, P., Lewis, J., McInnes, I. B., Oliver, S., Symmons, D. P. M., & McHugh, N. J. (2005) · Rheumatology · doi:10.1093/rheumatology/keh514 · Cited by 143
Harashima, S.-I., Horiuchi, T., Hatta, N., Morita, C., Higuchi, M., Sawabe, T., Tsukamoto, H., Tahira, T., Hayashi, K., Fujita, S., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.130 · Cited by 129
Zou, J., Rudwaleit, M., Brandt, J., Thiel, A., Braun, J., & Sieper, J. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.6.561 · Cited by 129
Goedkoop, A. Y., Kraan, M. C., Picavet, D. I., de Rie, M. A., Teunissen, M. B. M., Bos, J. D., & Tak, P. P. (2004) · Arthritis Research & Therapy · doi:10.1186/ar1182 · Cited by 128
Yamada, Y., Sugita, S., Tanaka, H., Kamoi, K., Kawaguchi, T., & Mochizuki, M. (2009) · British Journal of Ophthalmology · doi:10.1136/bjo.2009.158840 · Cited by 124
Markham, T., Mullan, R. H., Golden‐Mason, L., Rogers, S. C. F., Bresnihan, B., FitzGerald, O., Fearon, U., & Veale, D. J. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.01.038 · Cited by 120
Mackey, A. C., Green, L., Leptak, C., & Avigan, M. (2009) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3181957a11 · Cited by 111
Atopic disorders in ankylosing spondylitis and rheumatoid arthritis
Rudwaleit, M., Andermann, B., Alten, R., Sörensen, H., Listing, J., Zink, A., Sieper, J., & Braun, J. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.11.968 · Cited by 111
Goedkoop, A. Y., Kraan, M. C., Teunissen, M. B. M., Picavet, D. I., de Rie, M. A., Bos, J. D., & Tak, P. P. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.018085 · Cited by 109
Zou, J., Rudwaleit, M., Brandt, J., Thiel, A., Braun, J., & Sieper, J. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10847 · Cited by 103
Immunomodulatory effects of etanercept on peripheral joint synovitis in the spondylarthropathies
Kruithof, E., Rycke, L. D., Roth, J., Mielants, H., den Bosch, F. E. V., Keyser, F. D., VEYS, E. M., & Baeten, D. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21426 · Cited by 90
Reactivation of hepatitis B in a patient with Crohn’s disease treated using infliximab
Ojiro, K., Naganuma, M., Ebinuma, H., Kunimoto, H., Tada, S., Ogata, H., Iwao, Y., Saito, H., & Hibi∥, T. (2008) · Journal of Gastroenterology · doi:10.1007/s00535-008-2165-x · Cited by 88
Discovery of TNF-α as a therapeutic target in rheumatoid arthritis: preclinical and clinical studies
Feldmann, M., & Maini, R. N. (2002) · Joint Bone Spine · doi:10.1016/s1297-319x(01)00335-9 · Cited by 84
Fautrel, B., Pham, T., Mouterde, G., Loët, X. L., Goupille, P., Guillemin, F., Ravaud, P., Cantagrel, A. G., Dougados, M., Puéchal, X., et al. (2007) · Joint Bone Spine · doi:10.1016/j.jbspin.2007.10.001 · Cited by 67
Nishida, K., Okada, Y., Nawata, M., Saito, K., & Tanaka, Y. (2008) · Endocrine Journal · doi:10.1507/endocrj.k07e-043 · Cited by 66
Gonnet-Gracia, C., Barnetche, T., Richez, C., Blanco, P., Dehais, J., & Schaeverbeke, T. (2008) · PubMed · Cited by 63
Development of Crohn’s disease following anti‐tumour necrosis factor therapy (etanercept)
Yazısız, V., Avci, A. B., Erbasan, F., Yıldırım, B., & Terzıoğlu, E. (2008) · Colorectal Disease · doi:10.1111/j.1463-1318.2008.01490.x · Cited by 59
Etanercept induces apoptosis of dermal dendritic cells in psoriatic plaques of responding patients
Malaviya, R., Sun, Y., Tan, J. K., Wang, A., Magliocco, M. A., Yao, M., Krueger, J. G., & Gottlieb, A. B. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.05.004 · Cited by 58
Treatment of HIV‐Related Inflammatory Cerebral Cryptococcoma with Adalimumab
Sitapati, A. M., Kao, C. L., Cachay, E. R., Masoumi, H., Wallis, R. S., & Mathews, W. C. (2009) · Clinical Infectious Diseases · doi:10.1086/649553 · Cited by 58
Cordiali‐Fei, P., Trento, E., D’Agosto, G., Bordignon, V., Mussi, A., Ardigò, M., Mastroianni, A., Vento, A., Solivetti, F. M., Berardesca, E., et al. (2006) · Journal of Autoimmune Diseases · doi:10.1186/1740-2557-3-5 · Cited by 56
The status of biologic therapies in the treatment of moderate to severe psoriasis.
Menter, A. (2009) · PubMed · Cited by 49
de Vries, H. S., van Oijen, M. G. H., & de Jong, D. J. (2008) · Drug Safety · doi:10.2165/0002018-200831120-00009 · Cited by 49
Programmed cell death of keratinocytes in infliximab-treated plaque-type psoriasis
Krüger‐Krasagakis, S., Galanopoulos, V. K., Giannikaki, L., Stefanidou, M. P., & Tosca, A. D. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.07078.x · Cited by 49
Tektonidou, M. G., & Skopouli, F. N. (2007) · Clinical Rheumatology · doi:10.1007/s10067-007-0775-y · Cited by 47
Herpes zoster in patients taking TNFα antagonists for chronic inflammatory joint disease
Wendling, D., Streit, G., Toussirot, É., et al. (2008) · Joint Bone Spine · doi:10.1016/j.jbspin.2007.10.011 · Cited by 46
Komatsuda, A., Wakui, H., Nimura, T., & Sawada, K. (2008) · Modern Rheumatology · doi:10.1007/s10165-008-0053-0 · Cited by 45
Sadowski, D. C., Bernstein, C. N., Bitton, A., Croitoru, K., Fedorak, R. N., Griffiths, A. M., & the CAG Crohn’s Consensus Group (2009) · Canadian Journal of Gastroenterology · doi:10.1155/2009/201430 · Cited by 45
Klimiuk, P. A., Sierakowski, S., Domysławska, I., Fiedorczyk, M., & Chwiećko, J. (2004) · PubMed · Cited by 45
İnanç, N., & Direskeneli, H. (2006) · Rheumatology International · doi:10.1007/s00296-006-0165-9 · Cited by 41
Lazzerini, P. E., Acampa, M., Hammoud, M., Maffei, S., Capecchi, P. L., Selvi, E., Bisogno, S., Guideri, F., Galeazzi, M., & Pasini, F. L. (2008) · PubMed · Cited by 39
Invasive Mucormycosis of the Maxillary Sinus: Extensive Destruction with an Indolent Presentation
Odessey, E. A., Cohn, A., Beaman, K. D., & Schechter, L. S. (2008) · Surgical Infections · doi:10.1089/sur.2006.039 · Cited by 37
Schotte, H., Schlüter, B., Willeke, P., Mickholz, E., Schorat, M. A., Domschke, W., & Gaubitz, M. (2004) · British journal of rheumatology · doi:10.1093/rheumatology/keh178 · Cited by 36
Interstitial granulomatous dermatitis in a patient with rheumatoid arthritis on etanercept.
Hu, S., Cohen, D. S., Murphy, G. F., Mody, E., & Qureshi, A. A. (2008) · PubMed · Cited by 32
Hepatotoxicity Associated with Etanercept in Psoriatic Arthritis
Leak, A. M., & RINCON-AZNAR, B. (2008) · The Journal of Rheumatology · doi:10.3899/jrheum.080521 · Cited by 31
Mancini, A. J., Jl, B., Jl, J., Rapini, R. P., Callen, J., Td, H., Aj, M., Salasche, S. J., Schaffer, J. V., Schwarz, T., et al. (2008) · Cited by 30
Overview of biologic therapy for Crohn's disease
Dryden, G. W. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903048909 · Cited by 29
Retinal vein thrombosis following infliximab treatment for severe left-sided ulcerative colitis
Veerappan, S. G., Kennedy, M., O’Morain, C. A., & Ryan, B. M. (2008) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e3282f376ac · Cited by 28
Fathalla, B. M., Goldsmith, D. P., Pascasio, J. M., & Baldridge, A. D. (2008) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0b013e318188b1df · Cited by 27
Pericarditis as a complication of infliximab therapy in Crohnʼs disease
Burke, J. P., Kelleher, B., Ramadan, S., Quinlan, M., SUGRUE, D. D., & OʼDonovan, M. A. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20270 · Cited by 26
Comte, C., Guilhou, J., Guillot, B., & Dereure, O. (2008) · Dermatology · doi:10.1159/000150603 · Cited by 26
Sinusitis: a possible link with adalimumab
Haroon, M., Bond, U., & Phelan, M. J. (2008) · Clinical Rheumatology · doi:10.1007/s10067-008-0948-3 · Cited by 24
Effects of infliximab treatment on rheumatoid synovial tissue.
Tak, P. P. (2005) · PubMed · Cited by 24
Kameda, T., Dobashi, H., Kittaka, K., Susaki, K., Hosomi, N., Deguchi, K., & Ishida, T. (2008) · Modern Rheumatology · doi:10.1007/s10165-008-0062-z · Cited by 22
Disseminated Cryptococcus neoformans after treatment with infliximab for rheumatoid arthritis
Kozic, H., Riggs, K., Ringpfeil, F., & Lee, J. B. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.12.015 · Cited by 22
Tuberculous peritonitis after treatment with adalimumab
Antolín, J. S., Azahara, M., Hernández, C., Blanco, M., Mao, L., & Cigüenza, R. (2008) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540701877320 · Cited by 20
Recurrent Varicella in an Adult Psoriasis Patient Treated with Etanercept
Becart, S., & Segaert, S. (2008) · Dermatology · doi:10.1159/000149311 · Cited by 19
Aggarwal, A., Panda, S., & Misra, R. (2004) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.012617 · Cited by 17
Adalimumab-induced bronchospasm: not a class effect
Janssen, R., Krivokuca, I., Kruize, A. A., Koenderman, L., & Lammers, J. J. (2008) · Thorax · doi:10.1136/thx.2007.086512 · Cited by 10
Les biothérapies immunomodulatrices du futur : quelles perspectives ?
Arnaud, L., Haroche, J., Pietté, J. C., & Amoura, Z. (2009) · La Presse Médicale · doi:10.1016/j.lpm.2008.12.023 · Cited by 7
Shigeyama (2000) · doi:10.1002/1529-0131(200011)43:11
Cited by
Interleukin-1 Beta as a Target for Atherosclerosis Therapy
Libby, P. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.09.028 · Cited by 619
Catanzaro, M., Fagiani, F., Racchi, M., Corsini, E., Govoni, S., & Lanni, C. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0191-1 · Cited by 605
CNS Demyelination with TNF-α Blockers
Kemanetzoglou, E., & Andreadou, E. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0742-1 · Cited by 319
Immune-mediated inflammatory diseases: common and different pathogenic and clinical features
Monteleone, G., Moscardelli, A., Colella, A., Marafini, I., & Salvatori, S. (2023) · Autoimmunity Reviews · doi:10.1016/j.autrev.2023.103410 · Cited by 105
Neuroinflammation in the Aging Down Syndrome Brain; Lessons from Alzheimer's Disease
Wilcock, D. M. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/170276 · Cited by 104
Metadata
- Authors
- Silva, L. C., Ortigosa, L. C., & Benard, G.
- Venue
- Immunotherapy
- Publisher
- Informa UK Limited
- Published
- 2010-11
- Volume
- 2
- Issue
- 6
- Pages
- 817-833
- ISSN
- 1750-743X (ISSN-L)
- 1750-7448
- OpenAlex
- W1965138135
- Cited by
- 216
- References
- 98
- FWCI
- 9.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.